NCGC00029283 is utilized in pharmacological research to study its efficacy and potential for developing anti-cancer drugs, as it possesses properties that inhibit cancer cell growth. Additionally, preliminary studies investigate its application in treating neurological disorders, where it demonstrates potential in improving neuronal function and reducing inflammation in the central nervous system. It serves as a potential lead compound in drug discovery and development, employed in high-throughput screening assays to evaluate efficacy and selectivity against proteins or enzymes implicated in diseases. Its applications also include optimizing pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, to enhance its viability as a drug candidate, as well as structural biology studies to understand binding interactions and design more potent and selective analogs.